OBJECTIVE: The purpose of this study was to determine whether there are differences in depression characteristics among premenopausal, perimenopausal, and postmenopausal women with major depressive disorder. This study also evaluated these differences between postmenopausal women with major depressive disorder who are taking and not taking hormone therapy. METHODS: Analyses conducted with data from the Sequenced Treatment Alternatives to Relieve Depression study focused on female outpatients with nonpsychotic major depressive disorder seeking treatment in 41 primary or psychiatric care settings across the United States. Baseline demographic and clinical characteristics were compared among women not taking hormone therapy who were premenopausal (n = 950), perimenopausal (n = 380), or postmenopausal (n = 562). These comparisons were also made between postmenopausal women (n = 768) taking (n = 171) or not taking (n = 562) hormone therapy. RESULTS: After adjusting for sociodemographic and clinical baseline differences, premenopausal women were more likely to present with irritability than were either perimenopausal or postmenopausal women and were more likely to have decreased appetite and less likely to have early-morning insomnia than were perimenopausal women. Postmenopausal women were more likely to have suicidal ideation and poorer physical functioning than were either of the other groups and were more likely to have sympathetic arousal and gastrointestinal symptoms than were premenopausal women. After adjusting for baseline differences, postmenopausal women taking hormone therapy had better physical functioning, fewer melancholic features, less sympathetic arousal, and more lack of involvement in activities than did women not taking hormone therapy. CONCLUSIONS: Menopause status and postmenopausal use of hormone therapy may influence the clinical presentation of major depressive episodes in women.
OBJECTIVE: The purpose of this study was to determine whether there are differences in depression characteristics among premenopausal, perimenopausal, and postmenopausal women with major depressive disorder. This study also evaluated these differences between postmenopausal women with major depressive disorder who are taking and not taking hormone therapy. METHODS: Analyses conducted with data from the Sequenced Treatment Alternatives to Relieve Depression study focused on female outpatients with nonpsychotic major depressive disorder seeking treatment in 41 primary or psychiatric care settings across the United States. Baseline demographic and clinical characteristics were compared among women not taking hormone therapy who were premenopausal (n = 950), perimenopausal (n = 380), or postmenopausal (n = 562). These comparisons were also made between postmenopausal women (n = 768) taking (n = 171) or not taking (n = 562) hormone therapy. RESULTS: After adjusting for sociodemographic and clinical baseline differences, premenopausal women were more likely to present with irritability than were either perimenopausal or postmenopausal women and were more likely to have decreased appetite and less likely to have early-morning insomnia than were perimenopausal women. Postmenopausal women were more likely to have suicidal ideation and poorer physical functioning than were either of the other groups and were more likely to have sympathetic arousal and gastrointestinal symptoms than were premenopausal women. After adjusting for baseline differences, postmenopausal women taking hormone therapy had better physical functioning, fewer melancholic features, less sympathetic arousal, and more lack of involvement in activities than did women not taking hormone therapy. CONCLUSIONS: Menopause status and postmenopausal use of hormone therapy may influence the clinical presentation of major depressive episodes in women.
Authors: L S Schneider; G W Small; S H Hamilton; A Bystritsky; C B Nemeroff; B S Meyers Journal: Am J Geriatr Psychiatry Date: 1997 Impact factor: 4.105
Authors: S G Kornstein; A F Schatzberg; M E Thase; K A Yonkers; J P McCullough; G I Keitner; A J Gelenberg; S M Davis; W M Harrison; M B Keller Journal: Am J Psychiatry Date: 2000-09 Impact factor: 18.112
Authors: S G Kornstein; A F Schatzberg; M E Thase; K A Yonkers; J P McCullough; G I Keitner; A J Gelenberg; C E Ryan; A L Hess; W Harrison; S M Davis; M B Keller Journal: J Affect Disord Date: 2000-10 Impact factor: 4.839
Authors: P J Schmidt; L Nieman; M A Danaceau; M B Tobin; C A Roca; J H Murphy; D R Rubinow Journal: Am J Obstet Gynecol Date: 2000-08 Impact factor: 8.661
Authors: S G Kornstein; A T Harvey; A J Rush; S R Wisniewski; M H Trivedi; D S Svikis; N D McKenzie; C Bryan; R Harley Journal: Psychol Med Date: 2005-05 Impact factor: 7.723
Authors: Elizabeth A Young; Susan G Kornstein; Anne T Harvey; Stephen R Wisniewski; Jennifer Barkin; Maurizio Fava; Madhukar H Trivedi; A John Rush Journal: Psychoneuroendocrinology Date: 2007-07-16 Impact factor: 4.905
Authors: Claudio N Soares; Michael E Thase; Anita Clayton; Christine J Guico-Pabia; Kristen Focht; Qin Jiang; Susan G Kornstein; Phillip T Ninan; Cecelia P Kane Journal: CNS Drugs Date: 2011-03 Impact factor: 5.749
Authors: Susan G Kornstein; Marisa Toups; A John Rush; Stephen R Wisniewski; Michael E Thase; James Luther; Diane Warden; Maurizio Fava; Madhukar H Trivedi Journal: J Womens Health (Larchmt) Date: 2013-02 Impact factor: 2.681
Authors: Carole Shum; Sara C Macedo; Katherine Warre-Cornish; Graham Cocks; Jack Price; Deepak P Srivastava Journal: Horm Behav Date: 2015-07-02 Impact factor: 3.587